Coxiella burnetii: host and bacterial responses to infection (Q36933983)

17 August 2017

1 reference

title

Coxiella burnetii: host and bacterial responses to infection (English)

1 reference

17 August 2017

1 reference

David M Waag

1

1 reference

PubMed ID

17825460

17 August 2017

language of work or name

English

0 references

publication date

20 August 2007

1 reference

17 August 2017

1 reference

17 August 2017

25

1 reference

17 August 2017

42

1 reference

17 August 2017

7288-7295

1 reference

A Filter-Passing Infectious Agent Isolated from Ticks

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Q fever studies in southern California; IX. Isolation of Q fever organisms from parturient placenta; of naturally infected dairy cows

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Q fever in California. IV. Occurrence of Coxiella burnetii in the placenta of naturally infected sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Phase variation of the Nine Mile and other strains of Rickettsia burneti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Coxiella burnetii: the 'query' fever bacterium. A model of immune subversion by a strictly intracellular microorganism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophila Dot/Icm system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Q fever during pregnancy: diagnosis, treatment, and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Q fever meningoencephalitis in a soldier returning from the Persian Gulf War.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Coxiella burnetii infection in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Risks factors and prevention of Q fever endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Long-term persistence of Coxiella burnetii after acute primary Q fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Cytokine dysregulation in the post-Q-fever fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Role for the CD28 molecule in the control of Coxiella burnetii infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Serological diagnosis of Q fever endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Validation of an enzyme immunoassay for serodiagnosis of acute Q fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Newer macrolides as empiric treatment for acute Q fever infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Lack of dendritic cell maturation following infection by Coxiella burnetii synthesizing different lipopolysaccharide chemotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

TLR2 is necessary to inflammatory response in Coxiella burnetii infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Interleukin-10 stimulates Coxiella burnetii replication in human monocytes through tumor necrosis factor down-modulation: role in microbicidal defect of Q fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Immune modulation by Coxiella burnetii: characterization of a phase I immunosuppressive complex differentially expressed among strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Injection of Inactivated Phase I Coxiella burnetii Increases Non-specific Resistance to Infection and Stimulates Lymphokine Production in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Intradermal Sensitivity Testing in Man with a Purified Vaccine for Q Fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Lesions in guinea pigs infected with Coxiella burnetii strain M-44

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Immunization experiments with recombinant Coxiella burnetii proteins in a murine infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Q fever: current concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Q fever and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Experimental Q fever infection in congenitally athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.002

7 January 2021

10.1016/J.VACCINE.2007.08.002

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17825460